Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Cytek Biosciences, Inc. (CTKB) had Cost of Goods Sold of $21.73M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$45.60M |
|
$-5.58M |
|
|
Cost of Goods Sold |
$21.73M |
$23.87M |
|
$56.23M |
|
$-10.62M |
|
$3.85M |
|
$-6.78M |
|
$-6.78M |
|
$-5.58M |
|
$-5.58M |
|
$-5.58M |
|
$-5.58M |
|
$-10.62M |
|
$-7.64M |
|
126.93M |
|
126.93M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$382.82M |
|
$18.35M |
|
$110.50M |
|
$493.32M |
|
$73.27M |
|
$0.79M |
|
$42.49M |
|
$115.76M |
|
$377.56M |
|
$342.25M |
|
$377.56M |
|
127.19M |
|
| Cash Flow Statement Financials | |
$-0.02M |
|
$-6.96M |
|
$-14.15M |
|
$98.75M |
|
$75.47M |
|
$-23.27M |
|
$13.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.22 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
52.34% |
|
-23.30% |
|
-23.30% |
|
-- |
|
-14.86% |
|
-12.24% |
|
$-2.39M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.44 |
|
0.81 |
|
110.98 |
|
-1.48% |
|
-1.63% |
|
-1.13% |
|
-1.48% |
|
$2.97 |
|
$-0.02 |
|
$-0.00 |
|